Financing equitable access to antiretroviral treatment in South Africa

被引:13
|
作者
Cleary, Susan [1 ]
McIntyre, Di [1 ]
机构
[1] Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa
来源
BMC HEALTH SERVICES RESEARCH | 2010年 / 10卷
基金
新加坡国家研究基金会;
关键词
HEALTH; POLITICS; THERAPY; CARE; MANAGEMENT; COSTS;
D O I
10.1186/1472-6963-10-S1-S2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: While South Africa spends approximately 7.4% of GDP on healthcare, only 43% of these funds are spent in the public system, which is tasked with the provision of care to the majority of the population including a large proportion of those in need of antiretroviral treatment (ART). South Africa is currently debating the introduction of a National Health Insurance (NHI) system. Because such a universal health system could mean increased public healthcare funding and improved access to human resources, it could improve the sustainability of ART provision. This paper considers the minimum resources that would be required to achieve the proposed universal health system and contrasts these with the costs of scaled up access to ART between 2010 and 2020. Methods: The costs of ART and universal coverage (UC) are assessed through multiplying unit costs, utilization and estimates of the population in need during each year of the planning cycle. Costs are from the provider's perspective reflected in real 2007 prices. Results: The annual costs of providing ART increase from US$ 1 billion in 2010 to US$ 3.6 billion in 2020. If increases in funding to public healthcare only keep pace with projected real GDP growth, then close to 30% of these resources would be required for ART by 2020. However, an increase in the public healthcare resource envelope from 3.2% to 5%-6% of GDP would be sufficient to finance both ART and other services under a universal system (if based on a largely public sector model) and the annual costs of ART would not exceed 15% of the universal health system budget. Conclusions: Responding to the HIV-epidemic is one of the many challenges currently facing South Africa. Whether this response becomes a "resource for democracy" or whether it undermines social cohesiveness within poor communities and between rich and poor communities will be partially determined by the steps that are taken during the next ten years. While the introduction of a universal system will be complex, it could generate a health system responsive to the needs of all South Africans.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Antiretroviral Treatment Outcomes amongst Older Adults in a Large Multicentre Cohort in South Africa
    Fatti, Geoffrey
    Mothibi, Eula
    Meintjes, Graeme
    Grimwood, Ashraf
    PLOS ONE, 2014, 9 (06):
  • [32] Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa
    Peltzer, Karl
    Friend-du Preez, Natalie
    Ramlagan, Shandir
    Anderson, Jane
    BMC PUBLIC HEALTH, 2010, 10
  • [33] Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion
    Bachmann, Max O.
    Timmerman, Venessa
    Fairall, Lara R.
    AIDS, 2015, 29 (17) : 2261 - 2268
  • [34] Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa Reply
    Mee, Paul
    Fielding, Katherine L.
    Charalambous, Salome
    Churchyard, Gavin J.
    Grant, Alison D.
    AIDS, 2009, 23 (07) : 872 - 873
  • [35] Validation and Improvement of a Machine Learning Model to Predict Interruptions in Antiretroviral Treatment in South Africa
    Esra, Rachel
    Carstens, Jacques
    Le Roux, Sue
    Mabuto, Tonderai
    Eisenstein, Michael
    Keiser, Olivia
    Orel, Erol
    Merzouki, Aziza
    De Voux, Lucien
    Maskew, Mhari
    Sharpey-Schafer, Kieran
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 92 (01) : 42 - 49
  • [36] Women's sexual scripting in the context of universal access to antiretroviral treatment-findings from the HPTN 071 (PopART) trial in South Africa
    Viljoen, Lario
    Hoddinott, Graeme
    Malunga, Samantha
    Vanqa, Nosivuyile
    Mhlakwaphalwa, Tembeka
    Marthinus, Arlene
    Mcimeli, Khanyisa
    Bond, Virginia
    Seeley, Janet
    Bock, Peter
    Hayes, Richard
    Reynolds, Lindsey
    BMC WOMENS HEALTH, 2021, 21 (01)
  • [37] Using quality improvement to accelerate highly active antiretroviral treatment coverage in South Africa
    Webster, Patty D.
    Sibanyoni, Maria
    Malekutu, Dinah
    Mate, Kedar S.
    Venter, W. D. Francois
    Barker, Pierre M.
    Moleko, Winnie
    BMJ QUALITY & SAFETY, 2012, 21 (04) : 315 - 324
  • [38] Antiretroviral Treatment Sharing among Female sex Workers Living with HIV in eThekwini (Durban), South Africa: Drivers and Implications for Treatment Success
    Rock, Amelia
    Comins, Carly
    Mulumba, Ntambue
    Young, Katherine
    Mcingana, Mfezi
    Guddera, Vijayanand
    Hausler, Harry
    Phetlhu, Rene
    Baral, Stefan
    Schwartz, Sheree
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2022, 21
  • [39] Does the Failure to Provide Equitable Access to Treatment Lead to Action by NHS Organisations? The Case of Biologics for South Asians with Inflammatory Bowel Disease
    Farrukh, Affifa
    Mayberry, John
    JOURNAL OF LAW AND MEDICINE, 2024, 31 (03)
  • [40] Equitable access to quality trauma systems in low-income and middle-income countries: assessing gaps and developing priorities in Ghana, Rwanda and South Africa
    Odland, Maria Lisa
    Abdul-Latif, Abdul-Malik
    Ignatowicz, Agnieszka
    Alayande, Barnabas
    Appia Ofori, Bernard
    Balanikas, Evangelos
    Bekele, Abebe
    Belli, Antonio
    Chu, Kathryn
    Ferreira, Karen
    Howard, Anthony
    Nzasabimana, Pascal
    Owolabi, Eyitayo O.
    Nyamathe, Samukelisiwe
    Pognaa Kunfah, Sheba Mary
    Tabiri, Stephen
    Yakubu, Mustapha
    Whitaker, John
    Byiringiro, Jean Claude
    Davies, Justine, I
    BMJ GLOBAL HEALTH, 2022, 7 (04):